Celther Polska is a young and dynamically developing biopharmaceutical enterprise with focus on commercialization of the proprietary research results in the following fields: • personalizaed therapy: targeted and cell therapies, • stem cells research: induced pluripotent stem cells (iPSC) and derivatives, • development of research models: primary cancer cell lines, • biomaterials: wound dressing material. Moreover, Celther Polska offers a broad range of services for life sciences related industries, such as: cytotoxicity, next genaration sequencing, cell line generation or genetic engineering services etc. For full list of services, please visit www.celther.com